Clinical Trials Browser

Interventional × rebastinib × Other hematologic neoplasm × Clear all

NCT00827138 2014-07-18

Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)

Phase 1 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive